Overview

6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension

Status:
Not yet recruiting

Trial end date:
2023-04-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) coload infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.

Phase:

N/A

Details

Lead Sponsor:

General Hospital of Ningxia Medical University

Treatments:

Hydroxyethyl Starch Derivatives